NCT01321723 - Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions

Postmenopausal Osteoporosis

Interventions

DRUG

PTH analog

A recombinant 1-31 amino acid fragment of PTH.

DRUG

Placebo

DRUG

Forsteo (Teriparatide)

A recombinant 1-34 amino acid fragment of PTH.

Trial Locations (4)

CCBR, Aalborg

CCBR, Ballerup Municipality

CCBR, Vejle

CCBR, Tallinn